Abstract
To analyze the predictors of therapeutic efficacy after intravesical botulinum toxin A injection for overactive bladder syndrome (OAB) refractory to antimuscarinic therapy. All consecutively OAB patients, who visited the urologic outpatient clinics of a medical center and refractory to antimuscarinic treatment, were prospectively enrolled. All enrolled patients received intravesical injection of 100 U onabotulinumtoxinA (Botox). The Global Response Assessment (GRA) score ≥ 2 at 3 months after Botox injection was defined as a successful treatment, otherwise failed. Overall, 89 patients received intravesical injection. Eighty patients, including 42 men and 38 women, had received follow-up at 3 months. The overall success rate was 63.8%. The global response assessment, urgency severity score, urgency, urgency urinary incontinence and frequency episodes, and functional bladder capacity improved after treatment. However, post-void residual volume (PVR) increased, and voiding efficiency (VE) decreased after treatment. Female gender (odds ratio = 3.75) was the only independent factor associated with the success. Female gender (coefficient = 0.74), low baseline overactive bladder symptoms score (coefficient = -0.12) and the presence of...Continue Reading
References
Jun 12, 1987·JAMA : the Journal of the American Medical Association·N M Resnick, S V Yalla
Aug 12, 1999·BJU International·P Abrams
Apr 18, 2000·Urology·C R Chapple
Jun 20, 2001·BJU International·Y YiangouP Anand
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Paul AbramsAlan Wein
May 12, 2004·Urology·Hann-Chorng Kuo
Mar 5, 2005·Neurourology and Urodynamics·Thomas M KesslerFiona C Burkhard
May 20, 2005·American Journal of Obstetrics and Gynecology·Matthias WernerBernhard Schüssler
Jul 5, 2005·Urology·Hann-Chorng Kuo
Jul 12, 2005·The Journal of Urology·Annabel NixonNorman Zinner
Aug 12, 2005·The Journal of Urology·A ApostolidisP Anand
Aug 12, 2005·The Journal of Urology·Roshni PopatProkar Dasgupta
Sep 13, 2005·BJU International·Govindaraj N RajkumarGraeme Conn
Nov 16, 2005·Urology·Hann-Chorng Kuo
Aug 15, 2006·Urology·Yukio HommaOsamu Nishizawa
May 19, 2007·The Journal of Urology·Arun SahaiProkar Dasgupta
Dec 13, 2007·European Urology·Thomas M Kessler
May 24, 2008·The Journal of Urology·Linda BrubakerUNKNOWN Pelvic Floor Disorders Network
Jul 1, 2011·Neurourology and Urodynamics·Hann-Chorng Kuo
Aug 10, 2011·Neurourology and Urodynamics·Iryna MakoveyR Corey O'Connor
Mar 14, 2012·BJU International·Adrian WaggEmad Siddiqui
Jul 24, 2012·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Hann-Chorng Kuo
Mar 16, 2013·Neurourology and Urodynamics·Sheng-Mou HsiaoHann-Chorng Kuo
Mar 13, 2014·PloS One·Yuan-Hong JiangHann-Chorng Kuo
Apr 24, 2014·International Journal of Clinical Practice·K-D SievertV W Nitti
Jul 1, 2014·Neurourology and Urodynamics·David James OsbornW Stuart Reynolds
Citations
Mar 7, 2017·Scientific Reports·Sheng-Mou HsiaoHann-Chorng Kuo
Oct 15, 2018·Pharmacological Reports : PR·Kajetan JuszczakTomasz Drewa
Dec 11, 2019·Neurourology and Urodynamics·Christopher ChermanskyArun Sahai
Apr 5, 2019·International Neurourology Journal·Sheng-Mou HsiaoHo-Hsiung Lin
Feb 15, 2020·Investigative and Clinical Urology·Jing-Liang Chen, Hann-Chorng Kuo
Jul 22, 2020·Der Urologe. Ausg. A·B K ZiegelmüllerR M Bauer
Jul 8, 2019·International Journal of Colorectal Disease·Ken ImaizumiMasaaki Ito
Oct 30, 2020·Neurourology and Urodynamics·Inés Ramírez-GarcíaEmília Sánchez